Clinical study of XiangShaLiuJunZi decoction combined with S-1 as maintenance therapy for stage III or IV gastric carcinoma and colorectal carcinoma

INTRODUCTION: S-1, a new oral fluorouracil chemotherapeutical drug, has been increasingly used in clinical maintenance after first-line chemotherapy for stage III or IV gastric carcinoma (GC) and colorectal carcinoma (CRC) for its own advantages. XiangshaLiujunzi Decoction (XSLJZD), a classic tradit...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Medicine (Baltimore)
Päätekijät: Hong, Xiao-Cui, Liang, Qi-Lian, Luo, Xing-Bo, Hu, Ke-Hui, Yang, Hai-Xia, Ou, Wen-ting, Zhang, Hui-Jie
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Wolters Kluwer Health 2020
Aiheet:
5700
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7440293/
https://ncbi.nlm.nih.gov/pubmed/32384478
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000020081
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia